The relationship between different genotypes of -2548 G/A LEP and Q223R LEPR polymorphisms with plasma leptin levels was investigated (Table 3) and no significant association was found between the levels of the hormone, -2548 G/A LEP polymorphism, and Q223R LEPR polymorphism and breast cancer (p > 0.05). Here, LEPR is linked to breast carcinoma.